RMD
ResMed Inc.
Price performance
Sep 18, 2026About
Company activity
20 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 09/01 | RMD | 8-K | ResMed Inc. Announces $450M Accelerated Share Repurchase Agreement | — | — | — |
| 08/17 | RMD | 8-K | ResMed Announces Leadership Transition with New Lead Director and Accounting Firm | — | — | — |
| 08/06 | RMD | 8-K | ResMed Inc. Announces 10% Quarterly Dividend Increase | — | — | — |
| 07/07 | RMD | 8-K | ResMed Announces Agreement to Sell MatrixCare Business | — | — | — |
| 04/30 | RMD | 8-K | ResMed Reports Strong Q3 2026 Results and Declares Quarterly Dividend | — | — | — |
| 04/30 | RMD | 8-K | ResMed Appoints New CFO as Brett Sandercock Retires | — | — | — |
| 01/29 | RMD | 8-K | ResMed Announces Strong Q2 2026 Financial Results and Dividend Declaration | — | — | — |
| 11/20/25 | RMD | 8-K | ResMed Inc. Announces Board Changes and Plan Amendments at Annual Meeting | — | — | — |
| 10/30/25 | RMD | 8-K | ResMed Reports Strong Q1 FY2026 Financial Results and Declares Quarterly Dividend | — | — | — |
| 08/18/25 | RMD | 8-K | ResMed Announces Board Changes with Election and Retirement | — | — | — |
| 08/01/25 | RMD | 8-K | ResMed Inc. Announces Departure of Chief Commercial Officer | — | — | — |
| 07/31/25 | RMD | 8-K | ResMed Declares $0.60 Quarterly Dividend and Reports Strong Q4 2025 Results | — | — | — |
| 04/23/25 | RMD | 8-K | ResMed Reports Strong Q3 2025 Financial Performance and Declares Quarterly Dividend | — | — | — |
| 01/30/25 | RMD | 8-K | ResMed Inc. Reports Strong Q2 2025 Financial Results and Declares Dividend | — | — | — |
| 11/21/24 | RMD | 8-K | ResMed Inc. Announces Annual Meeting Voting Results | — | — | — |
| 10/24/24 | RMD | 8-K | ResMed Announces Strong Q1 FY2025 Results and Dividend Declaration | — | — | — |
| 08/16/24 | RMD | 8-K | ResMed Appoints Experienced Healthcare Executive and CFO to Board | — | — | — |
| 08/01/24 | RMD | 8-K | ResMed Announces Strong Q4 FY 2024 Results and Dividend | — | — | — |
| 04/25/24 | RMD | 8-K | ResMed Reports Strong Q1 2024 Financial Results and Announces Dividend | — | — | — |
| 01/24/24 | RMD | 8-K | ResMed Announces Q2 2024 Results and Dividend | — | — | — |
RMD filing record
ResMed Inc. (RMD): 20 8-K filings summarized, the most recent on Sep 1, 2026.
What the 8-K filings said
- Sep 1, 2026 · medium impact
On August 31, 2026, ResMed Inc. entered into an accelerated share repurchase agreement with Citibank, N.A. to repurchase $450.0 million of its shares of common stock. The transaction is funded by the proceeds from the sale of its MatrixCare business and cash on hand. The repurchase is part of a previously announced…
ResMed Inc. Announces $450M Accelerated Share Repurchase Agreement - Aug 17, 2026 · medium impact
ResMed Inc. announced on August 13, 2026, the dismissal of KPMG LLP as its independent registered public accounting firm and the appointment of PricewaterhouseCoopers LLP for the fiscal year ending June 30, 2027. Simultaneously, the company disclosed that Ron Taylor, a director, will retire after more than 21 years of…
ResMed Announces Leadership Transition with New Lead Director and Accounting Firm - Aug 6, 2026 · medium impact
ResMed Inc. announced a 10% increase in its quarterly cash dividend to $0.66 per share, effective from the quarter ending June 30, 2026. The company also reported strong financial results for the quarter and fiscal year, with revenue growth of 9% and 10% respectively, and a 16% increase in non-GAAP diluted earnings…
ResMed Inc. Announces 10% Quarterly Dividend Increase - Jul 7, 2026 · high impact
ResMed Inc. announced on July 7, 2026, that it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners for $490 million in an all-cash transaction. The sale is expected to close during the first quarter of fiscal year 2027, subject to regulatory approvals and customary…
ResMed Announces Agreement to Sell MatrixCare Business - Apr 30, 2026 · medium impact
ResMed Inc. announced its financial results for the third quarter of fiscal year 2026, reporting an 11% increase in revenue to $1.4 billion and a 21% increase in non-GAAP diluted earnings per share to $2.86. The company also declared a quarterly cash dividend of $0.60 per share, payable on June 18, 2026. ResMed's…
ResMed Reports Strong Q3 2026 Results and Declares Quarterly Dividend
SEC filings in the last five years
- 32 Form 8-K
- 14 Form 10-Q
- 4 Form 10-K
- 2 Form 8-K/A